Markers of increased cardiovascular risk: Are we measuring the most appropriate parameters?

被引:19
作者
Hawkins, MA [1 ]
机构
[1] Albert Einstein Coll Med, Dept Med, Div Endocrinol, Ctr Diabet Res & Training, Bronx, NY 10461 USA
来源
OBESITY RESEARCH | 2004年 / 12卷
关键词
cardiovascular disease risk; high-density lipoprotein/total cholesterol ratio; small dense low-density lipoproteins; C-reactive protein; postprandial glucose levels;
D O I
10.1038/oby.2004.275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vital task of evaluating cardiovascular disease risk in individual patients is challenging in light of the ever-growing list of risk factors. Some of the traditional measures of cardiovascular risk, such as blood lipid levels, have been further refined to provide better risk assessments. Certain specific parameters, such as lipoprotein buoyancy, seem to be better predictors of cardiovascular disease than total lipoprotein levels. Furthermore, as the contribution of systemic inflammation to the pathogenesis of atherosclerosis is increasingly. recognized, several inflammatory markers have become associated with disease risk. Consequently, many studies have attempted to determine the individual merits of these factors in predicting cardiovascular risk.
引用
收藏
页码:107S / 114S
页数:8
相关论文
共 54 条
[1]   TISSUE-TYPE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR IN DIABETES-MELLITUS [J].
AUWERX, J ;
BOUILLON, R ;
COLLEN, D ;
GEBOERS, J .
ARTERIOSCLEROSIS, 1988, 8 (01) :68-72
[2]   Surgical removal of visceral fat reverses hepatic insulin resistance [J].
Barzilai, N ;
She, L ;
Liu, BQ ;
Vuguin, P ;
Cohen, P ;
Wang, JL ;
Rossetti, L .
DIABETES, 1999, 48 (01) :94-98
[3]  
Borch-Johnsen K, 1999, LANCET, V354, P617
[4]   Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects [J].
Calles-Escandon, J ;
Mirza, SA ;
Sobel, BE ;
Schneider, DJ .
DIABETES, 1998, 47 (02) :290-293
[5]   SUSCEPTIBILITY OF SMALL, DENSE, LOW-DENSITY LIPOPROTEINS TO OXIDATIVE MODIFICATION IN SUBJECTS WITH THE ATHEROGENIC LIPOPROTEIN PHENOTYPE, PATTERN-B [J].
CHAIT, A ;
BRAZG, RL ;
TRIBBLE, DL ;
KRAUSS, RM .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (04) :350-356
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[8]  
Despres JP, 1996, EUR HEART J, V17, P1453
[9]   HDL-cholesterol as a marker of coronary heart disease risk:: the Quebec cardiovascular study [J].
Després, JP ;
Lemieux, I ;
Dagenais, GR ;
Cantin, B ;
Lamarche, B .
ATHEROSCLEROSIS, 2000, 153 (02) :263-272
[10]   POSTCHALLENGE GLUCOSE-CONCENTRATION AND CORONARY HEART-DISEASE IN MEN OF JAPANESE ANCESTRY - HONOLULU HEART PROGRAM [J].
DONAHUE, RP ;
ABBOTT, RD ;
REED, DM ;
YANO, K .
DIABETES, 1987, 36 (06) :689-692